Businessweek

Express Scripts Holding Company (NasdaqGS:ESRX) is seeking acquisitions. Jeff Hall, Executive Vice President and Chief Financial Officer of Express Scripts, said, "After that comes M&A, good, accretive M&A. We have got two great examples in recent history with the WellPoint business and the Medco business, which are generating very large positive returns for us and certainly to the extent we can find other deals like that, we are excited to get out there and do those strong deals."

Express Scripts Holding Company Presents at UBS Global Healthcare Conference, May-21-2013 01:30 PM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Jeffrey L. Hall, Chief Financial Officer and Executive Vice President.

Express Scripts Holding Company reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported revenues of $26,063.0 million against $12,132.6 million for the same period last year. Operating income was $841.9 million against $566.9 million for the same period last year. Income before income taxes was $637.9 million against $437.2 million for the same period last year. Net income attributable to the company was $378.1 million or $0.45 per diluted share against $267.8 million or $0.55 per diluted share for the same period last year. Net income from continuing operations was $379.3 million or $0.45 per diluted share against $270.2 million or $0.55 per diluted share a year ago. Net cash provided by operating activities was $963.4 million against $532.1 million for the same period last year. Purchases of property and equipment were $108.9 million against $18.7 million for the same period last year. EBITDA from continuing operations, attributable to the company, as reported was $1,437.4 million against $629.5 million a year ago. Adjusted EBITDA from continuing operations, attributable to the company was $1,592.0 million against $656.2 million a year ago. Total EPS attributable to the company, adjusted was $0.99 against $0.73 a year ago. Adjusted EBITDA from continuing operations attributable to Express Scripts per adjusted claim was $4.08, up 20%. The company repaid another $1.5 billion of debt and ended the quarter with $2 billion of cash. For the year, the company previously provided adjusted earnings per diluted share from continuing operations attributable to the company in the range of $4.20 to $4.30, or growth of 12% to 15% over 2012. The company expects improvements in gross profit over the balance of the year and now anticipates achieving adjusted earnings per diluted share from continuing operations attributable to the company for 2013 in the range of $4.23 to $4.33, or 13% to 16% growth over 2012.

Express Scripts Holding Company, Q1 2013 Earnings Call, Apr 30, 2013

Express Scripts Holding Company announced that they will report Q1, 2013 results at 5:00 PM, Eastern Standard Time on Apr 29, 2013